Trial Profile
Retrospective, Real-life Observational Evaluation of the Effectiveness and Cost-effectiveness of Extra-fine Hydrofluoroalkane (HFA) Beclometasone (BDP) Compared With Fluticasone Propionate (FP) in the Management of Asthma in a Representative Population in the United States (US)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary) ; Fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms USQvarAsthma
- 09 Feb 2011 New trial record